Repeats of DNA sequences, often referred to as "junk DNA" or "dark matter," that are found in chromosomes and could contribute to cancer or other diseases have been challenging to identify and characterize.
Mar 13, 2024
0
95
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential clues to why some ...
Mar 7, 2024
0
597
Autopsy has a central role in shedding light on diseases, helping to uncover the cause of death. Tissue samples from various organs are sampled, stained, and examined under a light microscope to evaluate their histological ...
Feb 26, 2024
0
14
The Wistar Institute's associate professor Mohamed Abdel-Mohsen, Ph.D., has demonstrated, with his lab and collaborators, a connection between viral damage to the gut and premature biological aging.
Feb 22, 2024
0
15
An analysis of the sudden global outbreak of hepatitis in children finds that although the primary suspect is highly likely to be an infection by multiple viruses, many questions still puzzle researchers.
Feb 21, 2024
0
0
Males born to obese women are more likely to be overweight at birth and develop metabolic complications in later life, including liver disease and diabetes. The way that male sex hormones activate pathways in the developing ...
Feb 6, 2024
0
0
New research has mapped changes in tumor-related bacteria to uncover potential new strategies to combat the rise of young-onset colorectal cancer (CRC) in people under the age of 50.
Feb 5, 2024
0
39
Human pathologists are extensively trained to detect when tissue samples from one patient mistakenly end up on another patient's microscope slides (a problem known as tissue contamination). But such contamination can easily ...
Jan 23, 2024
0
0
A large team of medical researchers affiliated with multiple entities in the U.S. and China has found that the risk of developing type 2 diabetes is reduced for people with a certain gene variant.
Cedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test ...
Jan 22, 2024
0
55
